The development of inhibitors of PI3K and Akt

被引：0
|
作者：
Dennis, PA [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [1] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [2] Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancer
    Barra, Fabio
    Evangelisti, Giulio
    Desideri, Lorenzo Ferro
    Di Domenico, Stefano
    Ferraioli, Domenico
    Vellone, Valerio Gaetano
    De Cian, Franco
    Ferrero, Simone
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (02) : 131 - 142
  • [3] Predictive and pharmacodynamic (PD) markers of PI3K pathway inhibitors: focus on PI3K, AKT and mTOR inhibitors
    Tabernero, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S6 - S6
  • [4] PI3K/Akt/mTOR inhibitors in breast cancer
    Joycelyn JX Lee
    Kiley Loh
    Yoon-Sim Yap
    Cancer Biology & Medicine, 2015, (04) : 342 - 354
  • [5] PI3K/Akt/mTOR inhibitors in breast cancer
    Lee, Joycelyn J. X.
    Loh, Kiley
    Yap, Yoon-Sim
    CANCER BIOLOGY & MEDICINE, 2015, 12 (04) : 342 - 354
  • [6] Clinical development of inhibitors of the PI3K
    Saura Manich, C.
    CANCER RESEARCH, 2019, 79 (04)
  • [7] Synthesis and biological activity of Akt/PI3K inhibitors
    Redaelli, C.
    Granucci, F.
    De Gioia, L.
    Cipolla, L.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (10) : 1127 - 1136
  • [8] PI3K/AKT/mTOR Inhibitors In Ovarian Cancer
    Mazzoletti, M.
    Broggini, M.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (36) : 4433 - 4447
  • [9] PI3K/Akt/mTOR inhibitors in breast cancer
    Joycelyn JX Lee
    Kiley Loh
    Yoon-Sim Yap
    Cancer Biology & Medicine, 2015, 12 (04) : 342 - 354
  • [10] Development of Inhibitors of the IGF-IR/PI3K/Akt/mTOR Pathway
    Hixon, Mary L.
    Paccagnella, Luisa
    Millham, Robert
    Perez-Olle, Raul
    Gualberto, Antonio
    REVIEWS ON RECENT CLINICAL TRIALS, 2010, 5 (03) : 189 - 208
12345